Cheap pandemic-era debt is turning toxic. As borrowing costs surge, hundreds of U.S. firms can no longer cover interest payments, raising the specter of “corporate zombies.” Intrasia Wealth examines what’s driving this trend, the risks for investors, and how disciplined credit selection can turn volatility into opportunity.